Matches 51 - 100 out of 186 < 1 2 3 4 >
Match Document Document Title
6214812 Bisphosphonate conjugates and methods of making and using the same  
Bisphosphonate conjugates capable of releasing antibacterial and/or cytotoxic components upon binding with bone tissue. Such conjugates are useful in the treatment and prevention of bone cancer,...
6200961 Concentrates of organophosphorous insecticides  
A low volatile organic compound co-solvent system is disclosed for preparing emulsion concentrates of low melting organophosphorous insecticides wherein the bioefficacy of the insecticide active is...
6190695 Pharmaceutical composition containing osteogenesis-promoting substance  
This invention provides a pharmaceutical composition comprising a non-peptide osteogenesis-promoting substance and a polyethylene glycol or a derivative thereof, which can be advantageously used as...
6177411 Method for treating heavy metal poisoning  
This invention relates to a method of treating patients afflicted with heavy metal poisoning. The method includes administering to a patient in need of treatment an antidotal amount of a thiol or...
6174857 Composition and method for the treatment of osteoporosis in mammals  
Pharmaceutical compositions and methods for the treatment of osteoporosis in mammals are disclosed. The compositions are suitable for parenteral administration and comprise Insulin-Like Growth...
6172119 Method of treating acute renal failure  
This invention relates to a method of treating patients afflicted with acute renal failure. The method includes administering to a patient in need of treatment an effective amount of a thiol or...
6133261 Amino acid derivatives useful to treat stroke  
The invention provides a therapeutic method for treating or preventing stroke and other ischemic disorders, as well as novel compounds and pharmaceutical compositions useful for carrying out such...
6117856 Topical bisphosphonates for prevention of bone resorption  
Bisphosphonates inhibit bone resorption associated with periodonatal or orthopedic surgery when applied topically to the bone. A novel formulation for topical application contains a gelatin matrix...
6114340 Fungicidal compositions  
An improved fungicidal composition is a mixture of (a) fungicide used to combat phytopathogenic fungi and (b) at least one phosphonate or phosphinate of formula R 1 R 2 P(O)OR 3 where R 1 is C...
6114316 Combination of bisphosphonate and tetracycline  
Tissue-destructive conditions related to excess protemase activity in a biological system are treated or prevented by administering to the system a composition which combines a tetracycline and a...
6100247 Method of treating diabetic neuropathy  
This invention relates to a method of treating patients afflicted with diabetic neuropathy. The method includes administering to a patient in need of treatment an effective amount of a thiol or...
6087349 Method for blocking neoplastic transformation of cells induced by ras oncogenes  
A method is provided by blocking or preventing the prenylation of CAAX box containing proteins including ras oncogene products thereby preventing and/or treating ras-related tumors which includes...
6057306 Method of treating the navicular disease in horses  
The invention relates to a method of treating the navicular disease in horses, which comprises treating the navicular disease in horses with an effective amount of at least one compound of formula...
6043274 Method of treating diabetic cardiomyopathy  
This invention relates to a method of treating patients afflicted with diabetic cardiomyopathy. The method includes administering to a patient in need of treatment an effective amount of a thiol or...
6034126 Method for treating glycol poisoning  
This invention relates to a method of treating patients afflicted with glycol poisoning. The method includes administering to a patient in need of treatment an antidotal amount of a thiol or...
6008205 Polyisoprenyl phosphate stable analogs for regulation of neutrophil responses  
The present invention is directed to presqualene diphosphate (PSDP) analogs having an active region of natural PSDP and a metabolic transformation region resistant to rapid intracellular...
6008207 Anhydrous alendronate monosodium salt formulations  
Disclosed is a method for treating and preventing bone loss in patients by administering a formulation of anhydrous alendronate sodium. Also described is a pharmaceutical doage form of said...
6008206 Sodium alendronate preparation for local administration  
The object of the present invention is to provide a preparation for local administration to permit selective delivery of an effective amount of sodium alendronate to the bone site where bone...
5998479 Method of treating adult respiratory syndrome  
This invention relates to a method of treating patients afflicted with Adult Respiratory Distress Syndrome (ARDS). The method includes administering to a patient in need of treatment an effective...
5990098 Therapeutic use of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid and its salts  
Use of 1-amino-3-N,N-dimethylamino)-propyliden-1,1-bisphosphonic acid of the structural formula: ##STR1## or of its monosodium or other pharmaceutically acceptable salt, as a biological carrier for...
5972913 Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices  
Disclosed is a therapy for treating and for preventing periprosthetic bone loss by the administration of a bisphosphonate bone resorption inhibitor, e.g., alendronate, in patients who have an...
5968498 Freshness retaining gel composition  
The freshness of meat, vegetables and fruits in a refrigerator or food storage box can be retained for a long period of time by using (1) a freshness retaining gel composition which comprises a...
5965547 Use of certain methanebishosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration  
The invention relates to the use of certain methanebisphosphonic acid derivatives (for the manufacture of a pharmaceutical composition) for the prevention and treatment of prosthesis loosening and...
5958906 Phospholipid derivatives containing higher elements of the fifth main group  
Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared...
5958907 Pharmaceutical compositions and uses of inorganic pyrophosphates  
Pharmaceutical compositions comprising an inorganic pyrophosphate (PPi) in a form that renders the PPi accessible to ABC proteins when administered to a subject in vivo, as well as use of the...
5932563 Methods for treating spinal cord injury  
New methods for treating patients with a traumatic contusion-type spinal cord injury are provided. The method comprises the steps of providing a patient having a contusion-type injury and...
5914323 Intravenous alendronate formulations  
Disclosed is a therapy protocol for treating patients having metastatic bone disease, hypercalcemia of malignancy and/or metabolic bone disease by administering an intravenous, citrate-buffered...
5914099 Prevention of tooth loss by the administration of alendronate or its salts  
Alendronate, a bisphosphonate can prevent tooth loss not necessarily associated with periodontal disease. Preferably, alendronate (or a pharmaceutically acceptable salt thereof) is given daily for...
5858996 Compositions and methods for stabilizing polymers  
Compositions and methods for reducing the decomposition rate of polymeric bioadhesives and viscosity enhancers, such as poly(acrylic acids). The compositions include at least one strong, stable...
5843993 Hydroxyalkyl phosphine gold complexes for use as diagnostic and therapeutic pharmaceuticals and method of making same  
A complex and method for making same for use as a diagnostic or therapeutic pharmaceutical includes a ligand comprising at least one hydroxyalkyl phosphine donor group bound to a gold atom to form...
5824661 Sulfur-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism  
Compounds of the formula ##STR1## where m and n are integers 0 to 10 and m+n equals 0 to 10, (a) X is O or S (b) Z is a covalent bond; a monocyclic or polycyclic carbocycle ring moiety; or a...
5804570 Method of lessening the risk of non-vertebral bone fractures  
Alendronate, a bisphosphonate, when administered daily over a substantial period of time, can reduce the rate of non-vertebral fractures, in post-menopausal women.
5712261 Method for preventing or treating hypertriglyceridemia  
A method is provided for preventing and/or treating hypertriglyceridemia, and/or atherosclerosis and/or pancreatitis resulting from hypertriglyceridemia, employing a squalene synthetase inhibitor.
5668120 Iontophoretic delivery of bisphosphonates to the alveolar bone  
The present invention relates to methods of inhibiting alveolar bone resorption or the undesirable movement of teeth of a human or other animal comprising: a) administering a reservoir to the...
5616571 Bisphosphonates prevent bone loss associated with immunosuppressive therapy  
Bisphosphonate, particularly alendronate, can prevent or treat bone loss associated with immunosuppressive therapy, whether or not the immunosuppressive therapy is associated with an organ transplant.
5616576 Controlling bone resorption with pyrroloquinoline quinone (PQQ) and related compounds  
PQQ and PQQ-generating compounds inhibit osteoclast cell formation and bone resorption, and those compounds can be used to treat medical conditions characterized by undesired bone resorption....
5591730 Inhibition of urinary calculi growth  
The present invention provides metal ion/bisphosphonate complexes that are useful for the treatment and diagnosis of urinary calculi. Preferred bisphosphonates include etidronate, pamidronate...
5488041 Method of promoting bone repair using tiludronic disodium salt  
The present invention relates to a method of promoting bone repair in human or veterinary medicine; which method comprises the administration of therapeutically effective amounts of bisphosphonic...
5466682 Acylamino-alkyliden-hydroxy-bisphosphonic acids esters and salts thereof, wherein the acyl group is derived from an acid having antiinflammatory activity  
Compounds of formula (I) ##STR1## in which A is (CH 2 ) n in which n is 1-10, preferably 3 or 5, and R is the acyl group from a known anti-inflammatory agent, exhibit high anti-inflammatory...
5462932 Oral liquid alendronate formulations  
Disclosed is a therapy protocol for treating and for preventing bone loss in patients who have difficulty in swallowing by administering a liquid formulation of alendronate which can be easily...
5461039 Method for treating hypertension employing a cholesterol lowering drug  
A method is provided for treating hypertension in normotensive patients having insulin resistance by administering a cholesterol lowering drug, such as pravastatin, alone or in combination with an...
5457083 Synergistic antimicrobial combination of polyether phosphonates and non-oxidizing biocides  
Synergistic antimicrobial combinations of polyether polyamino methylene phosphonates and one or more members selected from the group consisting essentially of the following non-oxidizing biocides: ...
5451401 Diphosphonic acid esters as tartar control agents  
Polyphosphonic acid ester compounds with flavorant, coolant and/or sweetener components, and tartar, plaque and/or calculus control compositions with improved taste comprising one or more...
5438048 Methylenebisphosphonic acid derivatives  
Novel pharmacologically active methylenebisphosphonates having formula (I) wherein R 1 , R 2 , R 3 and R 4 independently are straight or branched, optionally unsaturated C 1 -C 10 -alkyl,...
5434145 N-alkythio polyamine derivatives as radioprotective agents  
The present invention relates to certain polyamine thiols which are useful as radioprotective agents.
5431920 Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents  
The present invention relates to a novel oral dosage form of a bisphosphonic active ingredient for use in treatment of diseases involving bone resorption and formulated in an enteric-coated form...
5428028 Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor  
A method is provided for inhibiting cholesterol biosynthesis by inhibiting de novo squalene production employing methylene phosphonoalkylphosphinate compounds.
5403829 Use of bisphosphonates in endo-osteal bone surgery  
A method of enhancing the formation of bone tissue and/or eliminating late complications subsequent to bone surgery comprising administering an amount, which is safe and sufficient to promote the...
5376649 Partial esters of (Di) chloromethanediphosphonic acid useful for treating disorders relating to the metabolism of calcium  
Novel pharmaceutically active bisphosphonic acid derivatives of formula (I), in which R 1 , R 2 , R 3 and R 4 independently are C 1 -C 22 -alkyl, C 2 -C 22 -alkenyl, C 2 -C 22 -alkynyl, C 3...
5369099 Method and composition for inhibiting the formation of hardwater deposits on fruit  
The present invention provides an improved method and mixture for cooling fruit on the tree or vine while inhibiting the formation of scales or deposits on the fruit. The method and mixture provide...
Matches 51 - 100 out of 186 < 1 2 3 4 >